1. Successful treatment of complement mediated refractory hemolysis associated with cold and warm autoantibodies using eculizumab;Bommer;Haematologica,2011
2. Multicenter phase III study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria;Brodsky;Blood,2008
3. How I treat paroxysmal nocturnal hemoglobinuria;Brodsky;Blood,2009
4. ClinicalTrials.gov. 2011. A service of the U.S. National Institutes of Health. http://clinicaltrials.gov/ct2/show/NCT01335165.
5. ClinicalTrials.gov. 2011.A service of the U.S. National Institutes of Health. http://clinicaltrials.gov/ct2/show/NCT01303952.